0000899243-16-027019.txt : 20160812 0000899243-16-027019.hdr.sgml : 20160812 20160812181500 ACCESSION NUMBER: 0000899243-16-027019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160811 FILED AS OF DATE: 20160812 DATE AS OF CHANGE: 20160812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feinberg Barry I CENTRAL INDEX KEY: 0001614566 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 161829442 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE, SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-11 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001614566 Feinberg Barry I C/O BIODELIVERY SCIENCES INTL, INC., 4131 PARKLAKE AVENUE, SUITE 225 RALEIGH NC 27612 1 0 0 0 Common Stock 2016-08-11 4 M 0 10000 0.00 A 58500 I Trust Common Stock 2016-08-11 4 M 0 15000 0.00 A 73500 I Trust Restricted Stock Units 0.00 2016-08-11 4 M 0 10000 0.00 D 2016-08-11 2016-08-11 Common Stock 10000 0 D Restricted Stock Units 0.00 2016-08-11 4 M 0 15000 0.00 D 2016-08-11 Common Stock 15000 15000 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of 10,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on July 16, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended. The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on June 30, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2017 Annual Meeting of Stockholders. These shares are owned by a joint revocable living Trust, of which the Reporting Person is a trustee. /s/ Barry I Feinberg 2016-08-12